摘要
目的改进达比加群酯的合成工艺,提高反应收率并简化操作。方法以4-甲胺基-3-硝基苯甲酸为原料,与3-(吡啶-2-基氨基)丙酸乙酯缩合后,经催化氢化、酰胺化后闭环、成脒、与氯甲酸正己酯反应得到达比加群酯。结果与结论目标化合物的结构经核磁共振氢谱、质谱确证。改进后的合成方法与原工艺相比,环境友好,收率提高了16.4%,总收率为33.75%(以4-甲胺基-3-硝基苯甲酸计)。
Dabigatran etexilate,an oral direct thrombin inhibitor(DTI),is an effective drug for thromboembolic diseases.A new economical and environmental friendly synthetic method was developed.Firstly,4-(methylamino)-3-nitrobenzoic acid was reacted with ethyl 3-(pyridin-2-ylamino)propanoate(2) under the catalysis of 2-chloro-1-methylpyridinium iodide(CMPI) to give ethyl 3-[4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido] propanoate(4),4 was reduced to get ethyl 3-[3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido] propanoate(5),then 5 was reacted with 2-(4-cyanophenylamino)acetic acid(6) to get ethyl 3-{2-[(4-cyanophenylamino)methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzoimidazole-5-carboxamido}propanoate(7),7 was reacted with hydroxylamine hydrochloride then reduced in the presence of HCOONH4 and Pd/C to get ethyl 3-{2-[(4-carbamimidoyl-phenylamino)methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzoimidazole-5-carboxamido}propanoate(8),finally,8 was reacted with hexyl carbonochloridate(9) to afford dabigatran etexilate(1).The overall yield was about 33.75%,which increased by 16.4% based on 4-(methylamino)-3-nitrobenzoic acid.The chemical structure of dabigatran etexilate was characte-rized by MS,1H-NMR.Compared with the original synthetic process,the new route is facile and suitable for industrialized production with lower pollution and higher yield.
出处
《中国药物化学杂志》
CAS
CSCD
2012年第3期204-208,共5页
Chinese Journal of Medicinal Chemistry
关键词
工艺改进
化学合成
达比加群酯
process improvement
chemical synthesis
dabigatran etexilate